|
|
||||||||
Department of Radiology, Faculty of Medicine, Kyushu University, Higashi-ku, Fukuoka, Japan
Correspondence: For correspondence or reprints contact Masayuki Sasaki, MD, Department of Radiology, Faculty of Medicine. Kyushu University, 3-1-1 Maidashi, Higashiku, Fukuoka 812, Japan.
ABSTRACT
We have encountered two cases of bone tumors with high 18F-fluorodeoxyglucose (FDG) uptake and negative 99mTc-HMDP bone scintigraphy, including a patient with myeloma and a patient with a metastatic bone tumor from esophageal cancer. Bone scintigraphy with a 99mTc-phosphate complex reflects osteoblastic activity in the bone tissue surrounding the tumor, whereas the accumulation of FDG is associated with the metabolic activity of the tumor itself. An FDG-PET study can therefore be used as a complementary study for the detection and follow-up of bone tumors when a 99mTc-phosphate bone scintigram is negative.
This article has been cited by other articles:
![]() |
E. J. C. Angtuaco, A. B. T. Fassas, R. Walker, R. Sethi, and B. Barlogie Multiple Myeloma: Clinical Review and Diagnostic Imaging Radiology, April 1, 2004; 231(1): 11 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schulte, D. Brecht-Krauss, B. Heymer, A. Guhlmann, E. Hartwig, M. R. Sarkar, C. G. Diederichs, A. V. Baer, J. Kotzerke, and S. N. Reske Grading of Tumors and Tumorlike Lesions of Bone: Evaluation by FDG PET J. Nucl. Med., October 1, 2000; 41(10): 1695 - 1701. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |